Phil McElnay, a medical doctor with a vast background in the pharmaceutical and technology industries, has solid experience in medical affairs, scientific strategy, clinical research, medical education, epidemiology, medicine, and surgery. Equipped with a distinction higher degree focused on clinical research, Phil has proven his passion for entrepreneurial endeavors as CEO of MedAll. His education and training include a Diploma of Membership of the Royal College of Surgeons, an MSc in Medical Education from the University of Bristol, an M.B.B.S in Medicine from The University of Glasgow, and an MSc in Clinical Research with Distinction from Newcastle University.

Phil's career path has involved several notable positions, such as Editorial Board Member at Annals of Translational Medicine, Medical Director - Global Medical Affairs at GSK, and Journal and News Scan Editor at CTSNet / Cardiothoracic Surgeons Network. Additionally, he has been a part of the International Guidelines Committee- Mesothelioma (Lung Cancer) at the European Respiratory Society and served as the Honorary Secretary of the Association of Surgeons in Training. He has also held academic clinical roles at Newcastle University and University Hospitals Bristol NHS Foundation Trust.

Phil McElnay is a proven entrepreneur and medical doctor with expertise in clinical research, medical affairs, medical education, epidemiology, and surgery. His areas of interest include pharmaceuticals and technology, surgical and medical education, scientific strategy, and clinical research.